Exercise and Neuropathic Pain: A General Overview of Preclinical and Clinical Research

被引:0
|
作者
Brianna N. Leitzelar
Kelli F. Koltyn
机构
[1] University of Wisconsin-Madison,Department of Kinesiology
来源
Sports Medicine - Open | 2021年 / 7卷
关键词
Pain management; Exercise training; Physical activity;
D O I
暂无
中图分类号
学科分类号
摘要
Neuropathic pain is a disease of the somatosensory system that is characterized by tingling, burning, and/or shooting pain. Medication is often the primary treatment, but it can be costly, thus there is an interest in understanding alternative low-cost treatments such as exercise. The following review includes an overview of the preclinical and clinical literature examining the influence of exercise on neuropathic pain. Preclinical studies support the hypothesis that exercise reduces hyperalgesia and allodynia in animal models of neuropathic pain. In human research, observational studies suggest that those who are more physically active have lower risk of developing neuropathic pain compared to those who are less active. Exercise studies suggest aerobic exercise training (e.g., 16 weeks); a combination of aerobic and resistance exercise training (e.g., 10–12 weeks); or high-intensity interval training (e.g., 15 weeks) reduces aspects of neuropathic pain such as worst pain over the past month, pain over the past 24 h, pain scores, or pain interference. However, not all measures of pain improve following exercise training (e.g., current pain, heat pain threshold). Potential mechanisms and future directions are also discussed to aid in the goal of understanding the role of exercise in the management of neuropathic pain. Future research using standardized methods to further understanding of the dose of exercise needed to manage neuropathic pain is warranted.
引用
收藏
相关论文
共 50 条
  • [1] Exercise and Neuropathic Pain: A General Overview of Preclinical and Clinical Research
    Leitzelar, Brianna N.
    Koltyn, Kelli F.
    [J]. SPORTS MEDICINE-OPEN, 2021, 7 (01)
  • [2] Role of Exercise on Neuropathic Pain in Preclinical Models: Perspectives for Neuroglia
    Zhu, Chen-Chen
    Zheng, Yi-Li
    Gong, Chan
    Chen, Bing-Lin
    Guo, Jia-Bao
    [J]. MOLECULAR NEUROBIOLOGY, 2024,
  • [3] Bibliometric Analysis of Exercise and Neuropathic Pain Research
    Chen, Yu-Meng
    Wang, Xue-Qiang
    [J]. JOURNAL OF PAIN RESEARCH, 2020, 13 : 1533 - 1545
  • [4] Preclinical Neuropathic Pain Assessment; the Importance of Translatability and Bidirectional Research
    Fisher, Amy S.
    Lanigan, Michael T.
    Upton, Neil
    Lione, Lisa A.
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [5] NEUROPATHIC PAIN - AN OVERVIEW
    MEYERSON, BA
    [J]. ADVANCES IN PAIN RESEARCH AND THERAPY, 1990, 13 : 193 - 199
  • [6] Neuropathic pain: An overview
    Bennett, GJ
    [J]. MOLECULAR NEUROBIOLOGY OF PAIN, 1997, 9 : 109 - 113
  • [7] Preclinical research in paclitaxel-induced neuropathic pain: a systematic review
    Bacalhau, Carolina
    Costa-Pereira, Jose Tiago
    Tavares, Isaura
    [J]. FRONTIERS IN VETERINARY SCIENCE, 2023, 10
  • [8] TRANSLATIONAL NEUROPATHIC PAIN RESEARCH: A CLINICAL PERSPECTIVE
    Bouhassira, D.
    Attal, N.
    [J]. NEUROSCIENCE, 2016, 338 : 27 - 35
  • [9] Treating neuropathic pain and comorbid affective disorders: Preclinical and clinical evidence
    Coelho, David Richer Araujo
    Gersten, Maia
    Jimenez, Alma Sanchez
    Fregni, Felipe
    Cassano, Paolo
    Vieira, Willians Fernando
    [J]. PAIN PRACTICE, 2024,
  • [10] Duloxetine: Summary of time to response in a preclinical and a clinical model of neuropathic pain
    Iyengar, S
    Pritchett, YL
    Hall, JA
    Chappell, AS
    Wernicke, JF
    Goldstein, DJ
    Simmons, RM
    Detke, MJ
    Shen, SY
    DSouza, DN
    Robinson, MJ
    [J]. NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S134 - S134